Fintel reports that on August 15, 2023, HC Wainwright & Co. reiterated coverage of TransCode Therapeutics (NASDAQ:RNAZ) with a Buy recommendation. As of August 2, 2023, the average one-year price ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results